샘플 요청 목록

 카트 문의
시장보고서
상품코드
1579677

세계의 임상시험 이미징 시장

Clinical Trial Imaging
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 78 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

임상시험 이미징 세계 시장은 2030년까지 14억 달러에 달할 것으로 예상됩니다

2023년 9억 8,060만 달러로 추정되는 임상시험 이미징 세계 시장은 2023년부터 2030년까지 연평균 5.5% 성장하여 2030년에는 14억 달러에 이를 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 프로젝트 및 데이터 관리 서비스는 CAGR 6.2%를 기록하여 분석 기간 종료 시점에 4억 7,280만 달러에 이를 것으로 예상됩니다. 운영 이미징 서비스 부문은 분석 기간 동안 CAGR 5.0%의 성장률을 나타낼 것으로 예상됩니다.

미국 시장은 2억 6,430만 달러로 추정, 중국은 CAGR 9.2%로 성장 전망

미국 임상시험 이미징 시장은 2023년 2억 6,430만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 9.2%의 연평균 복합 성장률(CAGR)로 2030년까지 3억 1,650만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 2.7%와 4.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 연평균 3.6%의 성장률을 보일 것으로 예상됩니다.

세계 임상시험 이미징 시장 - 주요 동향 및 촉진요인 요약

임상시험에 이미징이 필수적인 이유

영상진단은 새로운 치료법의 효과와 안전성에 대한 정확하고 정량적인 데이터를 제공함으로써 임상시험에서 필수적인 도구가 되고 있습니다. 임상시험 이미징은 MRI, CT 스캔, PET 스캔, 초음파 등 첨단 영상 진단 기법을 사용하여 임상시험 약물 및 시험 장비에 대한 생물학적 반응을 모니터링합니다. 영상 연구를 통해 연구자들은 해부학적 구조, 조직 구성 및 분자 활성의 변화를 평가하여 질병의 진행과 치료에 미치는 영향에 대한 명확한 통찰력을 얻을 수 있습니다. 예를 들어, 종양학 임상시험에서는 종양의 크기와 성장 속도를 측정하기 위해 이미지를 사용하고, 신경학 연구에서는 뇌의 구조적 변화와 신경 기능을 모니터링하는 데 도움이 됩니다. 이러한 시각적 데이터를 통해 연구자들은 다른 평가 방법으로는 볼 수 없는 변화를 감지할 수 있어 임상시험의 신뢰성을 높이고 규제 당국에 제출할 수 있는 증거를 제공할 수 있습니다. 임상시험이 복잡해짐에 따라 영상진단의 역할은 기본적인 평가를 넘어 연구자들이 데이터에 기반한 의사결정을 내리고, 임상시험의 위험을 줄이고, 임상시험 결과의 전반적인 정확성을 향상시키는 데 도움이 되고 있습니다.

기술의 발전은 임상시험 이미징을 어떻게 변화시킬 것인가?

영상 진단의 기술 발전은 임상시험의 판도를 바꾸고 있으며, AI와 머신러닝은 자동화된 영상 분석, 정량화 및 패턴 인식이 가능하기 때문에 이러한 변화를 촉진하는 중요한 요인으로 작용하고 있습니다. AI 기반 소프트웨어를 사용하면 연구자들은 시간이 지남에 따라 미묘한 변화를 식별하고 측정할 수 있어 치료 평가의 정확성을 높일 수 있습니다. 기능적 MRI(fMRI)나 양전자방사선단층촬영(PET)과 같은 첨단 영상 기법은 생리적 과정과 분자 경로에 대한 깊은 통찰력을 제공하여 암이나 신경퇴행성 질환과 같은 복잡한 질병을 연구하는 임상시험에 매우 유용합니다. 클라우드 컴퓨팅과 디지털 스토리지의 발전으로 전 세계 임상시험 기관 간 실시간 영상 공유와 협업이 용이해져 전문가들이 원격으로 데이터를 확인하고 분석할 수 있게 되었습니다. 또한, 3D 이미지와 디지털 바이오마커는 임상시험에서 중요한 도구로 등장하여 질병 마커를 매우 상세하게 시각화하고 정량화할 수 있게 되었습니다. 이러한 발전은 이미징 프로세스를 간소화할 뿐만 아니라 임상시험 데이터의 정확성과 일관성을 향상시켜 새로운 치료법 개발의 핵심 요소로 자리매김하고 있습니다.

어떤 치료 분야가 임상시험 이미징 수요를 주도하고 있는가?

임상시험 이미징에 대한 수요는 종양학, 신경학, 순환기학, 근골격계 질환 등 여러 치료 분야에서 증가하고 있습니다. 종양학은 종양의 성장, 전이, 새로운 암 치료에 대한 반응을 추적하기 위해 영상이 필수적이기 때문에 가장 큰 견인차 역할을 하고 있으며, PET 및 MRI와 같은 첨단 영상 진단 기술은 종양의 거동과 치료 효과를 모니터링하는 데 필요한 상세한 이미지를 제공합니다. 신경학에서는 알츠하이머병, 파킨슨병, 다발성 경화증과 같은 질환에서 뇌의 구조, 기능, 퇴행성 변화를 평가하는데 영상 진단이 필수적입니다. 순환기 임상시험에서도 심장 기능, 혈류, 심장 조직의 구조적 변화를 평가하기 위해 영상 진단이 많이 사용되고 있으며, 이는 심장 질환에 대한 새로운 약물이나 중재 방안을 평가하는 데 매우 중요합니다. 또한, 골관절염이나 류마티스 관절염과 같은 근골격계 질환을 연구하는 임상시험에서는 시간이 지남에 따라 뼈와 관절의 변화를 모니터링하기 위해 영상이 사용됩니다. 이러한 다양한 임상시험 영상에 대한 수요는 효과적인 치료법을 개발하기 위해 상세하고 정량화할 수 있는 데이터가 필수적인 중요한 치료 분야의 연구를 촉진하는 데 있어 임상시험 영상의 다재다능함과 중요한 역할을 강조하고 있습니다.

임상시험 이미징 시장의 성장 촉진요인은?

임상시험 이미징 시장의 성장은 임상시험의 복잡성, 영상 기술의 발전, 만성질환의 유병률 증가 등 여러 요인에 의해 이루어지고 있습니다. 임상시험이 복잡해지고 정확한 실시간 데이터가 요구되는 가운데, 영상진단은 환자의 반응을 모니터링하고 정량화할 수 있는 신뢰할 수 있는 솔루션을 제공하며, 암, 신경질환, 심혈관질환과 같은 복잡한 질환의 임상시험에 필수적인 요소로 자리 잡았습니다. 특히 AI를 활용한 영상 분석과 원격 데이터 공유 등의 기술 발전으로 영상 진단이 더욱 빠르고 쉽게 이용할 수 있게 되어 시험의 효율성과 정확성이 향상되고 있습니다. 특히 고령화 사회에서 만성질환과 퇴행성 질환의 확산으로 인해 임상시험에 대한 수요가 급증하고 있으며, 질병의 진행과 치료 효과를 추적하기 위한 영상 진단의 필요성이 더욱 커지고 있습니다. 또한, 규제 당국은 영상진단을 임상시험의 신뢰할 수 있는 평가지표로 인식하고 있으며, 다양한 임상시험에서 영상진단의 사용과 채택을 장려하고 있습니다. 원격지에서 영상진단을 수행하고 디지털 임상시험 워크플로우에 통합할 수 있는 분산형 임상시험과 원격의료의 등장은 다양한 환자군의 영상진단에 대한 접근성을 확대함으로써 시장 성장을 더욱 촉진하고 있습니다. 이러한 촉진요인을 종합하면, 임상시험 이미징 시장은 현대 의학 연구 수요를 충족시키기 위해 진화하고 있는 강력한 성장 궤도를 보이고 있습니다.

조사 대상 기업 예시(총 12건)

  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • ERT Clinical
  • Icon PLC
  • Image Core Lab
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Lyscaut Medical Imaging Company
  • Medical Metrics
  • Navitas Life Sciences
  • Parexel International Corporation
  • Perspectum Diagnostics
  • Prism Clinical Imaging
  • Quotient Sciences
  • Radiant Sage LLC
  • Resonance Health
  • Worldcare Clinical, LLC

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.11.12

Global Clinical Trial Imaging Market to Reach US$1.4 Billion by 2030

The global market for Clinical Trial Imaging estimated at US$980.6 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Project & Data Management Service, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$472.8 Million by the end of the analysis period. Growth in the Operational Imaging Services segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$264.3 Million While China is Forecast to Grow at 9.2% CAGR

The Clinical Trial Imaging market in the U.S. is estimated at US$264.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$316.5 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Clinical Trial Imaging Market - Key Trends & Drivers Summarized

Why Is Imaging Essential in Clinical Trials?

Imaging has become an indispensable tool in clinical trials, providing accurate and quantifiable data on the efficacy and safety of new treatments. Clinical trial imaging involves the use of advanced imaging modalities such as MRI, CT scans, PET scans, and ultrasound to monitor biological responses to investigational drugs or devices. Imaging allows researchers to assess changes in anatomy, tissue composition, and molecular activity, offering clear insights into disease progression and treatment impact. In oncology trials, for instance, imaging is used to measure tumor size and growth rates, while in neurology studies, it helps monitor structural changes in the brain and neurological function. This visual data enables researchers to detect changes that might be invisible to other assessment methods, enhancing the trial’s reliability and providing evidence to support regulatory submissions. As trials grow increasingly complex, the role of imaging has expanded beyond basic assessments, helping researchers make data-driven decisions, reduce trial risks, and improve the overall precision of study outcomes.

How Are Technological Advancements Transforming Clinical Trial Imaging?

Technological advancements in imaging are revolutionizing the clinical trial landscape, making imaging faster, more accurate, and more detailed than ever before. AI and machine learning are key drivers of this transformation, as they allow for automated image analysis, quantification, and pattern recognition. With AI-powered software, researchers can identify and measure even subtle changes over time, improving the precision of treatment assessments. Advanced imaging modalities, such as functional MRI (fMRI) and positron emission tomography (PET), provide deeper insights into physiological processes and molecular pathways, making them invaluable for trials studying complex diseases like cancer and neurodegenerative disorders. Cloud computing and digital storage advancements have also facilitated real-time image sharing and collaboration across global trial sites, ensuring that data can be reviewed and analyzed remotely by experts. Additionally, 3D imaging and digital biomarkers have emerged as critical tools in clinical trials, allowing for highly detailed visualization and quantification of disease markers. These advancements not only streamline the imaging process but also enhance the accuracy and consistency of trial data, making imaging a central component in the development of new therapies.

Which Therapeutic Areas Are Driving Demand for Clinical Trial Imaging?

The demand for clinical trial imaging is growing across multiple therapeutic areas, including oncology, neurology, cardiology, and musculoskeletal disorders. Oncology remains the largest driver, as imaging is essential for tracking tumor growth, metastasis, and response to novel cancer treatments. Advanced imaging techniques, such as PET and MRI, provide the detailed views needed to monitor tumor behavior and treatment efficacy. In neurology, imaging is crucial for evaluating brain structure, function, and degeneration in conditions like Alzheimer’s disease, Parkinson’s, and multiple sclerosis. Clinical trials in cardiology also heavily rely on imaging to assess cardiac function, blood flow, and structural changes in heart tissue, which are critical in evaluating new drugs or interventions for heart disease. Furthermore, clinical trials studying musculoskeletal disorders, such as osteoarthritis and rheumatoid arthritis, use imaging to monitor bone and joint changes over time. This diverse demand for clinical trial imaging underscores its versatility and critical role in advancing research across high-stakes therapeutic areas where detailed, quantifiable data is essential to developing effective treatments.

What’s Driving Growth in the Clinical Trial Imaging Market?

The growth in the clinical trial imaging market is driven by several factors, including the increasing complexity of clinical trials, advancements in imaging technology, and the rising prevalence of chronic diseases. As clinical trials become more complex, with demands for precise and real-time data, imaging provides a reliable solution for monitoring and quantifying patient responses, making it essential in trials for complex diseases like cancer, neurological disorders, and cardiovascular diseases. Technological advancements, particularly in AI-driven image analysis and remote data sharing, have made imaging faster and more accessible, improving trial efficiency and accuracy. The growing prevalence of chronic and degenerative diseases, especially in aging populations, has also led to a surge in demand for clinical trials, fueling the need for imaging to track disease progression and therapeutic impact. Additionally, regulatory authorities increasingly recognize imaging as a reliable endpoint in clinical trials, encouraging its use and adoption across various studies. The rise of decentralized trials and telemedicine, which allow imaging to be conducted remotely and integrated into digital trial workflows, further supports market growth by expanding access to imaging for diverse patient populations. These drivers collectively indicate a robust growth trajectory for the clinical trial imaging market as it evolves to meet the demands of modern medical research.

Select Competitors (Total 12 Featured) -

  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • ERT Clinical
  • Icon PLC
  • Image Core Lab
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Lyscaut Medical Imaging Company
  • Medical Metrics
  • Navitas Life Sciences
  • Parexel International Corporation
  • Perspectum Diagnostics
  • Prism Clinical Imaging
  • Quotient Sciences
  • Radiant Sage LLC
  • Resonance Health
  • Worldcare Clinical, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Clinical Trial Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Complexity of Clinical Trials Drives Demand for Advanced Imaging Solutions to Support Accurate Data Collection and Analysis
    • Rising Adoption of Imaging Biomarkers in Clinical Trials Expands Market for Clinical Trial Imaging Solutions Across Therapeutic Areas
    • Growing Emphasis on Precision Medicine and Personalized Therapies Spurs Demand for High-Resolution Imaging in Clinical Trials
    • Advancements in Artificial Intelligence and Machine Learning Propel Growth in Automated Image Analysis for Clinical Trials
    • Increasing Use of Imaging in Oncology Trials Strengthens Business Case for Specialized Clinical Trial Imaging Solutions
    • Rising Focus on Early Disease Detection in Clinical Trials Expands Use of Imaging Biomarkers for Predictive Insights
    • Expansion of Cardiovascular and Neurological Clinical Trials Drives Demand for Specialized Imaging Modalities and Analysis Tools
    • Increasing Investment in Advanced Imaging Technologies Propels Market Growth in Clinical Trial Imaging
    • Growing Use of PET, MRI, and CT Scans in Drug Development Expands Addressable Market for Clinical Trial Imaging Solutions
    • Rising Demand for Real-Time and Remote Imaging Capabilities Supports Adoption of Digital Imaging Solutions in Clinical Trials
    • Increased Adoption of Cloud-Based Imaging Platforms Facilitates Data Sharing and Expands Potential in Multi-Site Trials
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Clinical Trial Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Clinical Trial Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Clinical Trial Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Operational Imaging Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Operational Imaging Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Operational Imaging Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Project & Data Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Project & Data Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Project & Data Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reading & Analytical Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reading & Analytical Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Reading & Analytical Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Trial Design & Consultation Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Trial Design & Consultation Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Clinical Trial Design & Consultation Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for System & Technology Support Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for System & Technology Support Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for System & Technology Support Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Biotechnology & Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Biotechnology & Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Medical Devices Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Medical Devices Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Medical Devices Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Academic & Government Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Clinical Trial Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Clinical Trial Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Clinical Trial Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Clinical Trial Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Clinical Trial Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Clinical Trial Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • INDIA
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Clinical Trial Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Clinical Trial Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Clinical Trial Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Clinical Trial Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Clinical Trial Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Clinical Trial Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030
  • AFRICA
    • Clinical Trial Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Clinical Trial Imaging by Service - Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Clinical Trial Imaging by Service - Percentage Breakdown of Value Sales for Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Clinical Trial Design & Consultation Services and System & Technology Support Services for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Clinical Trial Imaging by End-Use - Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Clinical Trial Imaging by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Contract Research Organizations, Biotechnology & Pharmaceutical Companies, Medical Devices Manufacturers and Academic & Government Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제